英文别名 |
Vicenin-2;5,7-Dihydroxy-2-(4-hydroxyphenyl)-6,8-bis[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one;VICENIN;Vicenin II;5,7,4'-trihydroxyflavone 6,8-di-C-glucoside;6,8-Di-C-glucosylapigenin;Apigenin 6,8-C-diglucoside;Vicenin-II;6,8-Di-C-β-D-glucopyranosylapigenin;Apigenin 6,8-C-di-β-D-glucopyranoside;Apigenin 6,8-diglucoside;Vicenin 2;Vicenin -2;Violantin;Apigenin-6,8-di-C-glycoside;MLS000575019;5,7,4'-Trihydroxyflavone-6,8-di-C-glucoside;isovitexin 8-C-beta-glucoside;Apigenin 6,8-di-C-glucoside;isovitexin 8-C-glucoside;SureCN5826175;HMS2210F06;apigenin-6,8-di-C-glycopyranoside;BCP10896;9348AF;SMR000232371;C10195;666V139;Vicenin 2, primary;CS-0019465;6,8-di-c-glucosylapigenin;MS-30565;23666-13-9;DTXSID80904219;5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-bis[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one;AKOS015896841;Vicenin-II; 6,8-Di-C-glucosylapigenin;NCGC00247567-01;AC1L9D6K;Vicenin 2, primary pharmaceutical reference standard;SCHEMBL5826175;CHEBI:69814;CHEMBL1442950;ViceninII;1ST163797;MFCD08458851;5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-bis[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]chromen-4-one;Vicenin;AC-34904;HY-N2165;apigenin-6,8-C-diglucoside;6,8-Di-C-galactopyranosylapigenin;6-C-Glucopyranosyl-8-C-galactopyranosylapigenin;4',5,7-Trihydroxyflavone 6,8-di-C-glucoside;6,8-di-c-glucopyranosylapigenin;Vicenin 2;Vicenin2;Vicenin II;Apigenin-6,8-di-C-glycoside;FT-0775557;SCHEMBL22678703;4H-1-Benzopyran-4-one, 6,8-di-beta-D-glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-;AKOS040740193;Compound NP-000002;MEGxp0_000001;5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-bis[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one;FT-0778284;6,8-Di-b-D-glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one, 9CI;NP-000002(10);HMS3343G12;Apigenin 6,8-di-glucopyranoside;NS00097670;6,8-di-C-glucosyl-4',5,7-trihydroxyflavone |